SEARCH
The Swiss firm behind a possible Ebola vaccine
swissinfovideos
2014-11-14
Views
1
Description
Share / Embed
Download This Video
Report
An Ebola vaccine undergoing clinical trials in Lausanne was first developed by an Italian with venture capital from Basel. (SRG 10vor10, swissinfo.ch)
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x2a6jmc" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
00:39
Swiss trial of Canadian Ebola vaccine halted due to side effects
00:40
U.S. biotech firm Moderna to charge US$ 32~37 for COVID-19 vaccine
01:45
Biotech firms moving at unprecedented speed to develop COVID-19 vaccine
00:43
COVID-19 vaccine ng US Biotech Firm na Moderna, mabisa din sa mga 12-17 anyos
00:33
European Commission strikes deal with German biotech firm CureVac for potential COVID-19 vaccine
01:20
Carnaval de Bâle - Basel - Suisse Swiss Mov014 By Dan Bizet
00:43
Carnaval de Bâle - Basel - Suisse Swiss Mov005 By Dan Bizet
01:11
Rafael Nadal's practice at Swiss Indoors Basel. Oct. 17, 2014.
00:27
Sankt Gallen 2:1 Basel (Swiss Super League 20 September)
00:33
Lausanne 0:1 Basel (Swiss Super League. 2 December 2017)
00:23
Lausanne 0:2 Basel (Swiss Super League. 2 December 2017)
00:23
Luzern 1:1 Basel ( Swiss Super League. 25 November 2017)